These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6977219)

  • 21. Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.
    Yokoi T; Miyawaki T; Yachie A; Ohzeki S; Taniguchi N
    J Immunol; 1982 Oct; 129(4):1441-5. PubMed ID: 6980936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of autologous reactive helper T lymphocytes for differentiation of human B lymphocytes.
    Shin HS; Wang CY; Choi YS
    J Immunol; 1981 Jun; 126(6):2485-9. PubMed ID: 7014720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peripheral blood Ia-positive T lymphocytes detected by indirect antiglobulin rosetting reaction (IARR)].
    Matsumoto Y
    Rinsho Byori; 1983 Apr; 31(4):435-9. PubMed ID: 6352994
    [No Abstract]   [Full Text] [Related]  

  • 24. T cell tolerance: models for clinical application to allergy and autoimmunity.
    Schad VC
    Chem Immunol; 1994; 58():193-205. PubMed ID: 8011152
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-chain MHC class II molecules induce T cell activation and apoptosis.
    Rhode PR; Burkhardt M; Jiao J; Siddiqui AH; Huang GP; Wong HC
    J Immunol; 1996 Dec; 157(11):4885-91. PubMed ID: 8943392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the cellular requirements for human T cell transformation by a soluble mitogen derived from Mycoplasma arthritidis and concanavalin A.
    Daynes RA; Novak JM; Cole BC
    J Immunol; 1982 Sep; 129(3):936-8. PubMed ID: 6980925
    [No Abstract]   [Full Text] [Related]  

  • 27. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presentation in the immune response to infectious diseases.
    Pamer EG
    Clin Infect Dis; 1999 Apr; 28(4):714-6. PubMed ID: 10825024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and DR.
    Nose Y; Komori K; Inouye H; Nomura K; Yamamura M; Tsuji K
    Clin Exp Immunol; 1981 Jul; 45(1):152-7. PubMed ID: 7030536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Tac antigen on activated human T cells by anti-Tac monoclonal antibody.
    Tsudo M; Uchiyama T; Takatsuki K; Uchino H; Yodoi J
    J Immunol; 1982 Aug; 129(2):592-5. PubMed ID: 6979578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
    Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
    J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mouse anti-I region antiserum and complement on human mononuclear cell response to concanavalin A.
    Campbell DA; Oehler JR; Tsai CT; LoBuglio AF; Niederhuber JE
    J Immunol; 1982 May; 128(5):2057-62. PubMed ID: 6977582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B lymphocyte development and activation independent of MHC class II expression.
    Markowitz JS; Rogers PR; Grusby MJ; Parker DC; Glimcher LH
    J Immunol; 1993 Feb; 150(4):1223-33. PubMed ID: 8432977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.
    Murphy B; Akalin E; Watschinger B; Carpenter CB; Sayegh MH
    Transplant Proc; 1995 Feb; 27(1):409-10. PubMed ID: 7879041
    [No Abstract]   [Full Text] [Related]  

  • 35. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 36. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of IA in G-cell activation.
    Swain SL; Dutton RW
    Transplant Proc; 1981 Dec; 13(4):1843-5. PubMed ID: 6977219
    [No Abstract]   [Full Text] [Related]  

  • 38. Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens.
    Yu DT; McCune JM; Fu SM; Winchester RJ; Kunkel HG
    J Exp Med; 1980 Aug; 152(2 Pt 2):89s-98s. PubMed ID: 6967943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of autoantigen Ia recognition in T cell proliferative response].
    Ishii N; Nagai R; Okuda K
    Arerugi; 1983 Sep; 32(9):996-8. PubMed ID: 6607722
    [No Abstract]   [Full Text] [Related]  

  • 40. Level of Ia-like antigens on human B and T lymphocytes.
    Wilson BS; Indiveri F; Quaranta V; Pellegrino MA; Ferrone S
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1033-4. PubMed ID: 6973853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.